VOICE project aims to guide health services in their reorganization towards the provision of the highest value care for the patient at the best cost. VOICE is targeted to patients with breast and lung cancer. The purpose is to offer a new innovative strategic framework based on value-based healthcare model to these patients in Europe. VOICE Community consists of 13 hospitals across Europe working collaboratively to implement this approach. The Community addresses what matters most to patients by measuring patient reported health outcomes in routine clinical practice on a systematic and long-term basis, by including patients´ perspective in clinical decision-making, improving patient empowerment and physician-patient communication, assessing the impact on costs of the processes implemented, identifying factors for a successful implementation of value-based healthcare and boosting knowledge generation and best practice exchange across Europe. The VOICE ambition is to collect the health-related Quality of Life evidence from more than 1000 patients (patients with breast cancer and patients with lung cancer), by means of health related and patient reported questionnaires (ICHOM, International Consortium for Health Outcome Measurements, standard sets). Hospitals will go further by assessing the satisfaction, acceptability, relationship with professionals or decision-making process with patients. The VOICE Community will benchmark health outcomes and related costs to improve care delivery of these patients.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change from baseline overall well-being for patients with breast cancer at 6 months
Timeframe: Breast Cancer patients completed the PROMs questionnaires at baseline and after six months.. Lung Cancer patients completed the PROMs questionnaires at baseline, and after three and six months.
Change from baseline Asthenia and fatigue (including physical functioning) at 6 months
Timeframe: Breast Cancer patients completed the PROMs questionnaires at baseline and after six months.
Change from baseline Emotional functioning (also including anxiety and depression) for patients with breast cancer at 6 months
Timeframe: Breast Cancer patients completed the PROMs questionnaires at baseline and after six months.
Change from baseline Cognitive functioning for patients with breast cancer at 6 months
Timeframe: Breast Cancer patients completed the PROMs questionnaires at baseline and after six months.
Change from baseline Social and working functioning (also including financial impact) for patients with breast cancer at 6 months
Timeframe: Breast Cancer patients completed the PROMs questionnaires at baseline and after six months
Change from baseline Body image for patients with breast cancer at 6 months
Timeframe: Breast Cancer patients completed the PROMs questionnaires at baseline and after six months.
Change from baseline Sexual functioning for patients with breast cancer at 6 months
Timeframe: Breast Cancer patients completed the PROMs questionnaires at baseline and after six months.
Change from baseline Satisfaction with breasts for patients with breast cancer at 6 months
Timeframe: Breast Cancer patients completed the PROMs questionnaires at baseline and after six months.
Change from baseline Arm and breast symptoms for patients with breast cancer at 6 months
Timeframe: Breast Cancer patients completed the PROMs questionnaires at baseline and after six months.
Change from baseline Adverse effects: vasomotor symptoms for patients with breast cancer at 6 months
Timeframe: Breast Cancer patients completed the PROMs questionnaires at baseline and after six months.
Change from baseline Adverse effects: peripheral neuropathy for patients with breast cancer at 6 months
Timeframe: Breast Cancer patients completed the PROMs questionnaires at baseline and after six months.
Change from baseline Adverse effects: Arthralgia for patients with breast cancer at 6 months
Timeframe: Breast Cancer patients completed the PROMs questionnaires at baseline and after six months.
Change from baseline Vaginal symptoms for patients with breast cancer at 6 months
Timeframe: Breast Cancer patients completed the PROMs questionnaires at baseline and after six months.
Change from baseline Quality of life for patients with breast cancer at 6 months
Timeframe: Breast Cancer patients completed the PROMs questionnaires at baseline and after six months.
Change from baseline Global health status / Quality of life for patients with Lung Cancer at 6 months
Timeframe: Lung Cancer patients completed the PROMs questionnaires at baseline and after six months.
Change from baseline Fatigue for patients with lung cancer at 6 months
Timeframe: Lung Cancer patients completed the PROMs questionnaires at baseline and after six months.
Change from baseline Social function for patients with lung cancer at 6 months
Timeframe: Lung Cancer patients completed the PROMs questionnaires at baseline and after six months.
Change from baseline Physical functioning for patients with Lung Cancer at 6 months
Timeframe: Lung Cancer patients completed the PROMs questionnaires at baseline and after six months.
Change from baseline Emotional functioning for patients with lung cancer at 6 months
Timeframe: Lung Cancer patients completed the PROMs questionnaires at baseline and after six months.
Change from baseline Cognitive function for patients with Lung Cancer at 6 months
Timeframe: Lung Cancer patients completed the PROMs questionnaires at baseline and after six months.
Change from baseline Pain for patients with lung cancer at 6 months
Timeframe: Lung Cancer patients completed the PROMs questionnaires at baseline and after six months.
Change from baseline Shortness of breath for patients with Lung Cancer at 6 months
Timeframe: Lung Cancer patients completed the PROMs questionnaires at baseline and after six months.
Change from baseline Cough for patients with lung cancer at 6 months
Timeframe: Lung Cancer patients completed the PROMs questionnaires at baseline and after six months.